ciclopirox has been researched along with Carcinoma, Pancreatic Ductal in 1 studies
Carcinoma, Pancreatic Ductal: Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimura, K | 1 |
| Wright, T | 1 |
| Strnadel, J | 1 |
| Kaushal, S | 1 |
| Metildi, C | 1 |
| Lowy, AM | 1 |
| Bouvet, M | 1 |
| Kelber, JA | 1 |
| Klemke, RL | 1 |
1 other study available for ciclopirox and Carcinoma, Pancreatic Ductal
| Article | Year |
|---|---|
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Deoxycytidi | 2014 |